 Michael Alberti
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abiotrophia | 2 | 2016 | 2 | 1.040 |
Why?
| | Carnobacteriaceae | 2 | 2016 | 3 | 1.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2024 | 81 | 0.890 |
Why?
| | Genotyping Techniques | 1 | 2024 | 72 | 0.890 |
Why?
| | Adenoviridae | 2 | 2012 | 190 | 0.750 |
Why?
| | Myeloid Cells | 2 | 2012 | 142 | 0.730 |
Why?
| | Hematologic Neoplasms | 2 | 2021 | 139 | 0.690 |
Why?
| | Genetic Therapy | 2 | 2012 | 293 | 0.690 |
Why?
| | Myeloproliferative Disorders | 1 | 2018 | 26 | 0.600 |
Why?
| | Gene Duplication | 1 | 2018 | 68 | 0.590 |
Why?
| | Genetic Vectors | 3 | 2014 | 311 | 0.550 |
Why?
| | Disk Diffusion Antimicrobial Tests | 1 | 2016 | 1 | 0.530 |
Why?
| | Mice, Inbred C57BL | 4 | 2024 | 5257 | 0.530 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2065 | 0.520 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1667 | 0.510 |
Why?
| | Luciferases, Renilla | 1 | 2015 | 5 | 0.500 |
Why?
| | Internal Ribosome Entry Sites | 1 | 2015 | 4 | 0.490 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 17 | 0.490 |
Why?
| | Repressor Proteins | 1 | 2018 | 400 | 0.470 |
Why?
| | Virus Replication | 3 | 2015 | 444 | 0.470 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 485 | 0.470 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 92 | 0.450 |
Why?
| | Drug Monitoring | 1 | 2014 | 184 | 0.420 |
Why?
| | Protein Biosynthesis | 1 | 2015 | 397 | 0.410 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 475 | 0.410 |
Why?
| | Viral Tropism | 1 | 2012 | 28 | 0.410 |
Why?
| | Gene Transfer Techniques | 2 | 2014 | 161 | 0.400 |
Why?
| | Splicing Factor U2AF | 2 | 2021 | 16 | 0.380 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1182 | 0.370 |
Why?
| | Alleles | 2 | 2024 | 845 | 0.330 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1687 | 0.320 |
Why?
| | HIV-1 | 1 | 2015 | 840 | 0.320 |
Why?
| | Mutation | 2 | 2021 | 3692 | 0.300 |
Why?
| | Neoplasm Proteins | 2 | 2021 | 421 | 0.300 |
Why?
| | Peptide Fragments | 1 | 2012 | 685 | 0.290 |
Why?
| | Specimen Handling | 2 | 2019 | 165 | 0.260 |
Why?
| | Flow Cytometry | 2 | 2024 | 1141 | 0.250 |
Why?
| | RNA, Long Noncoding | 2 | 2017 | 178 | 0.220 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.220 |
Why?
| | B-Lymphocytes | 3 | 2021 | 820 | 0.200 |
Why?
| | Hepacivirus | 3 | 2010 | 234 | 0.190 |
Why?
| | Lymphopoiesis | 1 | 2021 | 26 | 0.190 |
Why?
| | Genes, Reporter | 3 | 2021 | 266 | 0.190 |
Why?
| | Inflammation | 1 | 2012 | 2664 | 0.180 |
Why?
| | Immunosuppressive Agents | 2 | 2016 | 686 | 0.180 |
Why?
| | Genotype | 3 | 2024 | 1831 | 0.180 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 237 | 0.180 |
Why?
| | Polymerase Chain Reaction | 1 | 2024 | 1019 | 0.180 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 169 | 0.180 |
Why?
| | Heterozygote | 1 | 2021 | 266 | 0.180 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 71 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 84 | 0.170 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 280 | 0.170 |
Why?
| | Mice | 8 | 2024 | 16579 | 0.170 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 110 | 0.170 |
Why?
| | Myelodysplastic Syndromes | 1 | 2021 | 129 | 0.170 |
Why?
| | Alternative Splicing | 1 | 2021 | 218 | 0.160 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 198 | 0.160 |
Why?
| | Leukemia | 1 | 2021 | 229 | 0.160 |
Why?
| | 5' Untranslated Regions | 2 | 2010 | 55 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2023 | 488 | 0.150 |
Why?
| | Biological Specimen Banks | 1 | 2019 | 96 | 0.150 |
Why?
| | Nucleic Acids | 1 | 2019 | 60 | 0.150 |
Why?
| | Artifacts | 1 | 2018 | 121 | 0.140 |
Why?
| | SOXC Transcription Factors | 1 | 2017 | 5 | 0.140 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 32 | 0.140 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2018 | 97 | 0.140 |
Why?
| | Histones | 1 | 2021 | 581 | 0.130 |
Why?
| | Molecular Typing | 1 | 2015 | 18 | 0.130 |
Why?
| | Transduction, Genetic | 2 | 2014 | 128 | 0.130 |
Why?
| | Immunoassay | 1 | 2016 | 103 | 0.130 |
Why?
| | Los Angeles | 1 | 2015 | 63 | 0.130 |
Why?
| | Humans | 18 | 2023 | 128524 | 0.130 |
Why?
| | Culture Media | 1 | 2016 | 167 | 0.130 |
Why?
| | beta-Lactams | 1 | 2015 | 26 | 0.130 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 136 | 0.120 |
Why?
| | Tacrolimus | 1 | 2016 | 138 | 0.120 |
Why?
| | Animals | 8 | 2024 | 34501 | 0.120 |
Why?
| | HEK293 Cells | 2 | 2021 | 681 | 0.120 |
Why?
| | O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 6 | 0.120 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2015 | 63 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 2 | 2015 | 377 | 0.120 |
Why?
| | Lentivirus | 1 | 2014 | 52 | 0.120 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 75 | 0.120 |
Why?
| | Blood Specimen Collection | 1 | 2014 | 33 | 0.120 |
Why?
| | Microbial Sensitivity Tests | 1 | 2015 | 335 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1416 | 0.110 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2015 | 195 | 0.110 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 521 | 0.110 |
Why?
| | Prognosis | 2 | 2018 | 3780 | 0.100 |
Why?
| | Down-Regulation | 1 | 2015 | 629 | 0.100 |
Why?
| | Kupffer Cells | 1 | 2012 | 49 | 0.100 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2012 | 142 | 0.100 |
Why?
| | Peptide Library | 1 | 2012 | 85 | 0.100 |
Why?
| | Hepatocytes | 1 | 2012 | 213 | 0.090 |
Why?
| | Bone Marrow Cells | 1 | 2012 | 294 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2017 | 591 | 0.090 |
Why?
| | Blotting, Western | 1 | 2012 | 1168 | 0.080 |
Why?
| | Gene Expression | 1 | 2014 | 1462 | 0.080 |
Why?
| | Translocation, Genetic | 2 | 2021 | 97 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1046 | 0.080 |
Why?
| | K562 Cells | 2 | 2021 | 82 | 0.080 |
Why?
| | Hepatitis C | 1 | 2010 | 233 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2012 | 701 | 0.070 |
Why?
| | Virus Cultivation | 1 | 2006 | 28 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2021 | 3160 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2021 | 2335 | 0.070 |
Why?
| | Protein Binding | 1 | 2012 | 2097 | 0.060 |
Why?
| | Macrophages | 2 | 2010 | 1463 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2021 | 1199 | 0.060 |
Why?
| | Gene Deletion | 1 | 2006 | 372 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2021 | 2752 | 0.060 |
Why?
| | Hepatitis C, Chronic | 1 | 2006 | 153 | 0.060 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2023 | 573 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1827 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1922 | 0.050 |
Why?
| | Tumor Stem Cell Assay | 1 | 2021 | 32 | 0.050 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 80 | 0.050 |
Why?
| | Genetic Variation | 1 | 2006 | 934 | 0.050 |
Why?
| | RNA, Neoplasm | 1 | 2021 | 87 | 0.050 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2021 | 50 | 0.050 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2021 | 87 | 0.040 |
Why?
| | Transgenes | 1 | 2021 | 177 | 0.040 |
Why?
| | Lung | 1 | 2012 | 3741 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2818 | 0.040 |
Why?
| | Tissue Fixation | 1 | 2019 | 34 | 0.040 |
Why?
| | Trans-Activators | 1 | 2021 | 381 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 758 | 0.040 |
Why?
| | Paraffin Embedding | 1 | 2019 | 27 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 581 | 0.040 |
Why?
| | Genetic Testing | 1 | 2021 | 427 | 0.040 |
Why?
| | Binding Sites | 1 | 2021 | 1239 | 0.040 |
Why?
| | Homeostasis | 1 | 2021 | 605 | 0.040 |
Why?
| | YY1 Transcription Factor | 1 | 2017 | 28 | 0.040 |
Why?
| | Sp1 Transcription Factor | 1 | 2015 | 25 | 0.030 |
Why?
| | Gene Order | 1 | 2014 | 26 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 311 | 0.030 |
Why?
| | Base Sequence | 2 | 2010 | 2134 | 0.030 |
Why?
| | Phylogeny | 2 | 2010 | 846 | 0.030 |
Why?
| | Gene Dosage | 1 | 2014 | 142 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3326 | 0.030 |
Why?
| | Fluorouracil | 1 | 2014 | 197 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2266 | 0.030 |
Why?
| | Cell Survival | 1 | 2015 | 1077 | 0.020 |
Why?
| | RNA | 1 | 2019 | 881 | 0.020 |
Why?
| | DNA | 1 | 2019 | 1392 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1820 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1333 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6297 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 330 | 0.020 |
Why?
| | Transcriptome | 1 | 2015 | 881 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4829 | 0.020 |
Why?
| | RNA, Viral | 1 | 2006 | 614 | 0.010 |
Why?
| | Female | 2 | 2023 | 68127 | 0.010 |
Why?
| | United States | 1 | 2016 | 13876 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4008 | 0.010 |
Why?
| | Child | 1 | 2017 | 20721 | 0.010 |
Why?
| | Time Factors | 1 | 2006 | 6503 | 0.010 |
Why?
| | Middle Aged | 1 | 2006 | 30893 | 0.000 |
Why?
|
|
Alberti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|